Founder Stack

Consint.AI Secures ₹22 Crore in Series A Funding t

Consint.AI Secures ₹22 Crore in Series A Funding to Scale Its Deeptech AI Platforms and Advance a Foundational Model for Fraud, Waste and Abuse Detection

· Funding · StartupTalky

Consint.AI Secures ₹22 Crore in Series A Funding. The funding round was backed by prominent technology investors, including BIG Global Investment JSC, Equanimity Ventures Trust II, and Seafund Venture India Scheme I. The funding round was backed by prominent technology investors, including BIG Global Investment JSC, Equanimity Ventures Trust II, and Seafund Venture India Scheme I. Consint.AI, a deeptech company transforming healthcare and insurance risk management through artificial intelligence, has raised ₹22 crore in Series A funding to accelerate its next phase of growth. The funding round was backed by prominent technology investors, includingBIG Global Investment JSC,Equanimity Ventures TrustII, andSeafund Venture India Scheme I. The fresh capital will be deployed to accelerate global expansion, deepen AI research, including the development of a foundational model purpose-built for fraud, waste and abuse (FWA) detection; strengthen enterprise delivery capabilities, and expand its portfolio of AI-powered healthcare and insurance solutions. Consint.AI has built a strong foundation of AI-driven innovation and measurable business impact across enterprise ecosystems with100+ million transactions assessed,identified over INR 10 billion in fraud using its 500+ AI/ML models, fine-tuned LLMs and 500+ digitised clinical protocols. The capital injection will drive expansion across platform innovation, technology capabilities, and global presence: a core focus of this round is building foundational models trained specifically for fraud, waste, and abuse (FWA) detection across the insurance, banking and financial services industry and delivering higher accuracy, faster inference, and data sovereignty for clients. Consint.AI will also deepen its focus on claims processing, document forensics, and clinical intelligence, and expand operations across India, the Middle East, Africa, the United States, and Southeast Asia.

Original source: StartupTalky
Read more on Founder Stack